Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.
Deshpande, A R
Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study. [electronic resource] - Alimentary pharmacology & therapeutics Sep 2011 - 586 p. digital
Publication Type: Letter; Comment
1365-2036
10.1111/j.1365-2036.2011.04778.x doi
Antibodies, Monoclonal--therapeutic use
Crohn Disease--diagnosis
Feces--chemistry
Female
Gastrointestinal Agents--therapeutic use
Humans
Leukocyte L1 Antigen Complex--metabolism
Male
Tumor Necrosis Factor-alpha--therapeutic use
Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study. [electronic resource] - Alimentary pharmacology & therapeutics Sep 2011 - 586 p. digital
Publication Type: Letter; Comment
1365-2036
10.1111/j.1365-2036.2011.04778.x doi
Antibodies, Monoclonal--therapeutic use
Crohn Disease--diagnosis
Feces--chemistry
Female
Gastrointestinal Agents--therapeutic use
Humans
Leukocyte L1 Antigen Complex--metabolism
Male
Tumor Necrosis Factor-alpha--therapeutic use